Report for the quarter ended 30th June 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Triochem Products Ltd has submitted its unaudited financial results for the quarter ended 30 June 2025, reviewed by statutory auditor Kanu Doshi Associates LLP who issued an unqualified conclusion. Revenue from operations stood at ₹22.10 lakhs, slightly down from ₹22.97 lakhs in the same quarter last year. Total expenses of ₹37.34 lakhs significantly exceeded revenue, resulting in a loss before tax of ₹15.24 lakhs, wider than the ₹9.62 lakh loss in Q1 FY25. After a deferred tax credit of ₹12.18 lakhs, the loss after tax narrowed to ₹3.06 lakhs (vs ₹7.80 lakh loss in Q1 FY25), with negative EPS of ₹1.25. The company reported no outstanding loan defaults and nil total financial indebtedness, and operates in a single segment of chemicals and pharmaceuticals.
The company remains loss-making at the operating level with expenses nearly 70% higher than revenue, indicating ongoing business stress, though bottom-line losses have narrowed due to tax adjustments. With zero debt and healthy reserves (₹1,342 lakhs in other equity), near-term solvency is not a concern, but shareholders should watch for sustained revenue growth to improve operating profitability.